The Relative Atherogenicity of VLDL and LDL is Dependent on the Topographic Site

Overview

Journal J Lipid Res

Publisher Elsevier

Specialty Biochemistry

Date 2010 Jan 21

PMID 20086185

Citations 8

Authors

Eline Van Craeyveld

Frank Jacobs

Yingmei Feng

Leen C J Thomassen

Johan A Martens

Joke Lievens

Jan Snoeys

Bart De Geest

Affiliations

Soon will be listed here.

Abstract

To evaluate whether the relative atherogenicity of VLDL and LDL is dependent on the topographic site, atherosclerosis was compared at four topographic sites in homozygous LDL receptor (LDLr)-deficient rabbits fed normal chow and in heterozygous LDLr-deficient rabbits with the same genetic background fed a 0.15% cholesterol diet to match cholesterol levels. VLDL cholesterol was significantly higher and LDL cholesterol significantly lower in LDLr(+/-) diet rabbits compared with LDLr(-/-) rabbits. Intimal area in the ascending thoracic aorta and in the abdominal aorta at the level of the renal arteries was 1.4-fold (P < 0.05) and 1.5-fold (P < 0.05) higher, respectively, in LDLr(-/-) rabbits than in LDLr(+/-) diet rabbits, whereas no significant difference occurred in the descending thoracic aorta and in the abdominal aorta just above the bifurcation. Differences remained statistically significant after adjustment for plasma cholesterol, triglycerides, and sex. Compared with LDLr(+/-) diet rabbits, higher intimal lipoprotein lipase (LPL) and apolipoprotein (apo) B levels were observed in LDLr(-/-) rabbits only at the level of the descending thoracic aorta. Intimal apo E levels in LDLr(-/-) rabbits were significantly lower in sites with a larger intima than in LDLr(+/-) diet rabbits. In conclusion, the relative atherogenicity of VLDL and LDL is dependent on the topographic site.

Citing Articles

Increased Remnant Lipoproteins in Apo E Deficient Mice Induce Coronary Atherosclerosis following Transverse Aortic Constriction and Aggravate the Development of Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure.

Muthuramu I, Mishra M, De Geest B Biomedicines. 2022; 10(7).

PMID: 35884897 PMC: 9312863. DOI: 10.3390/biomedicines10071592.

Thirty-Five-Year History of Desialylated Lipoproteins Discovered by Vladimir Tertov.

Glanz V, Bezsonov E, Soldatov V, Orekhov A Biomedicines. 2022; 10(5).

PMID: 35625910 PMC: 9138341. DOI: 10.3390/biomedicines10051174.

Sex as a Biological Variable in Atherosclerosis.

Man J, Beckman J, Jaffe I Circ Res. 2020; 126(9):1297-1319.

PMID: 32324497 PMC: 7185045. DOI: 10.1161/CIRCRESAHA.120.315930.

Blood flow patterns regulate PCSK9 secretion via MyD88-mediated pro-inflammatory cytokines.

Liu S, Deng X, Zhang P, Wang X, Fan Y, Zhou S Cardiovasc Res. 2019; 116(10):1721-1732.

PMID: 31593224 PMC: 8453289. DOI: 10.1093/cvr/cvz262.

The Correlation of Dyslipidemia with the Extent of Coronary Artery Disease in the Multiethnic Study of Atherosclerosis.

Abd Alamir M, Goyfman M, Chaus A, Dabbous F, Tamura L, Sandfort V J Lipids. 2018; 2018:5607349.

PMID: 29785308 PMC: 5892234. DOI: 10.1155/2018/5607349.

References

Majack R, Castle C, Goodman L, Weisgraber K, Mahley R, SHOOTER E . Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol. 1988; 107(3):1207-13. PMC: 2115305. DOI: 10.1083/jcb.107.3.1207. View

Veniant M, Sullivan M, Kim S, Ambroziak P, Chu A, Wilson M . Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100. J Clin Invest. 2000; 106(12):1501-10. PMC: 387257. DOI: 10.1172/JCI10695. View

Herijgers N, van Eck M, Groot P, Hoogerbrugge P, Van Berkel T . Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice. Arterioscler Thromb Vasc Biol. 1997; 17(10):1995-2003. DOI: 10.1161/01.atv.17.10.1995. View

Curtiss L, Boisvert W . Apolipoprotein E and atherosclerosis. Curr Opin Lipidol. 2000; 11(3):243-51. DOI: 10.1097/00041433-200006000-00004. View

OBrien K, Deeb S, Ferguson M, McDonald T, Allen M, Alpers C . Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol. 1994; 144(3):538-48. PMC: 1887086. View

Proctor S, Mamo J . Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2003; 23(9):1595-600. DOI: 10.1161/01.ATV.0000084638.14534.0A. View

Yamada N, Shames D, Stoudemire J, HAVEL R . Metabolism of lipoproteins containing apolipoprotein B-100 in blood plasma of rabbits: heterogeneity related to the presence of apolipoprotein E. Proc Natl Acad Sci U S A. 1986; 83(10):3479-83. PMC: 323539. DOI: 10.1073/pnas.83.10.3479. View

Feussner G, Wagner A, Kohl B, Ziegler R . Clinical features of type III hyperlipoproteinemia: analysis of 64 patients. Clin Investig. 1993; 71(5):362-6. DOI: 10.1007/BF00186624. View

McGill Jr H, McMahan C, Gidding S . Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 2008; 117(9):1216-27. DOI: 10.1161/CIRCULATIONAHA.107.717033. View

10.

Chung B, Tallis G, Yalamoori V, Anantharamaiah G, Segrest J . Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride-rich lipoproteins. Arterioscler Thromb. 1994; 14(4):622-35. DOI: 10.1161/01.atv.14.4.622. View

11.

Hui D . Apolipoprotein E-induced cell signaling in the vessel wall. Rev Endocr Metab Disord. 2004; 5(4):335-41. DOI: 10.1023/B:REMD.0000045105.26290.2d. View

12.

Yla-Herttuala S, Lipton B, Rosenfeld M, Goldberg I, Steinberg D, Witztum J . Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991; 88(22):10143-7. PMC: 52884. DOI: 10.1073/pnas.88.22.10143. View

13.

Hutter C, Austin M, Humphries S . Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview. Am J Epidemiol. 2004; 160(5):430-5. DOI: 10.1093/aje/kwh238. View

14.

Watanabe Y . Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 1980; 36(2):261-8. DOI: 10.1016/0021-9150(80)90234-8. View

15.

Yoon T, Mori N, Kitamura K, Ishibashi S, Shimano H, Mokuno H . Characterization of monoclonal anti-rabbit apolipoprotein E antibodies and chemical composition of lipoproteins separated by anti-apolipoprotein E immuno-affinity chromatography. J Biochem. 1991; 109(2):204-10. View

16.

Greenow K, Pearce N, Ramji D . The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl). 2005; 83(5):329-42. DOI: 10.1007/s00109-004-0631-3. View

17.

VanderLaan P, Reardon C, Getz G . Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol. 2003; 24(1):12-22. DOI: 10.1161/01.ATV.0000105054.43931.f0. View

18.

Methia N, Andre P, Denis C, Economopoulos M, Wagner D . Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood. 2001; 98(5):1424-8. DOI: 10.1182/blood.v98.5.1424. View

19.

Shimano H, Ohsuga J, Shimada M, Namba Y, Gotoda T, Harada K . Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest. 1995; 95(2):469-76. PMC: 295491. DOI: 10.1172/JCI117687. View

20.

Spagnoli L, Orlandi A, Mauriello A, Santeusanio G, De Angelis C, Lucreziotti R . Aging and atherosclerosis in the rabbit. 1. Distribution, prevalence and morphology of atherosclerotic lesions. Atherosclerosis. 1991; 89(1):11-24. DOI: 10.1016/0021-9150(91)90003-l. View